Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Magnus Ingelman‐Sundberg
Significantly Lower CYP2D6 Metabolism Measured as the O/N -Desmethylvenlafaxine Metabolic Ratio in Carriers of CYP2D6*41 Versus CYP2D6*9 or CYP2D6*10 - A Study on Therapeutic Drug Monitoring Data From 1,003 Genotyped Scandinavian Patients
British Journal of Clinical Pharmacology
Pharmacology
Related publications
The Effect of CYP2D6 Drug-Drug Interactions on Hydrocodone Effectiveness
Academic Emergency Medicine
Medicine
Emergency Medicine
The Impact of CYP2D6 Genotyping on Tamoxifen Treatment
Pharmaceuticals
Molecular Medicine
Pharmaceutical Science
CYP2D6 Genotype and Tardive Dyskinesia
British Journal of Psychiatry
Medicine
Psychiatry
Mental Health
Impact of CYP2D6 Phenotype on Tramadol Pharmacokinetics and Metabolic Pathways in Cancer Patients
Clinical Therapeutics
Pharmacology
CYP2D6-Mediated Mexiletine-Protein Adduct Formation
JOURNAL OF HEALTH SCIENCE
Transgenic Frequency of Japanese Human CYP2D6.
Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
Molecular Dynamics Simulation of CYP2D6 and CYP2C19
Proceedings for Annual Meeting of The Japanese Pharmacological Society
Clinical Inhibition of CYP2D6-catalysed Metabolism by the Antianginal Agent Perhexiline
British Journal of Clinical Pharmacology
Pharmacology
CYP2D6 Polymorphisms and Their Influence on Risperidone Treatment
Pharmacogenomics and Personalized Medicine
Molecular Medicine
Pharmacology
